Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2019-05-29
2023-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Postoperative, all patients will receive a morphine PCA. They will follow at 6, 12, 24 months for persistent postoperative surgical pain (PPSP) and cancer recurrence.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is PECS Block Equivalent to Paravertebral Block in Preventing Postoperative Pain After Breast Surgery?
NCT02645474
Preoperative Regional Nerve Block for Acute and Chronic Post-Operative Pain Following Mastectomy
NCT04019834
Pectoral Nerve Block for Analgesia After Breast Augmentation
NCT02682186
PECS Block With Bupivacaine Vs Bupivacaine and Dexmedetomidine in Modified Radical Mastectomy
NCT04284098
Continues Cicatricial Perfusion of Ropivacaine Versus Placebo After Mastectomy : Rehabilitation After Treatment
NCT02525211
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
All the patients also received a general anesthesia induced by propofol and esmeron for endotracheal intubation and desflurane for maintaining.
Sensory block by ice and pinprick test application and maximum spread after 40' from LA injection will be registered.
Postoperative, all patients will receive a morphine PCA, ketorolac 30 mg/12h and paracetamol 1g each 8h.
Morphine consumption will be registered. Patients will follow at 6, 12, 24 months for persistent postoperative surgical pain (PPSP) and cancer recurrence.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pectoral PECS II block
Ultrasound-guided PECS II block with ropivacaine 0.75% 20 ml (patients N = 75) + Parasternal ultrasound-guided block at T2, T4 levels with ropivacaine 0.375% 10 ml
PECSII and paravertebral blocks
Regional anesthesia for mastectomy outcomes
Paravertebral nerve block
Ultrasound-guided paravertebral block with ropivacaine 0.75% 20 ml at T1-T2 and T3-T4 levels (10 ml each) (patients N = 75)
PECSII and paravertebral blocks
Regional anesthesia for mastectomy outcomes
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PECSII and paravertebral blocks
Regional anesthesia for mastectomy outcomes
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age \> 18 y-o
* Written informed consent
Exclusion Criteria
* Opioids user
* BMI \> 35
* Postoperative Intensive care
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda USL Reggio Emilia - IRCCS
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
gianluca cappelleri, MD
Role: PRINCIPAL_INVESTIGATOR
AUSL IRCCS Reggio Emilia, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AUSL IRCCS Reggio Emilia
Reggio Emilia, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Breastblock
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.